BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
COVANCE, Inc. (NY: CVD)
95.10 USD  -0.01 (-0.01%)
Streaming Delayed Price  /  Updated: 10:31 AM EDT, Apr 24, 2014  /  Add to My Watchlist      
(CVD) Community Analysis from
April 24, 2014
(Stock Blog Hub, 4/27/13)
Covance Inc. (CVD) recently announced that it had completed the expansion of its central laboratory facility in Singapore. Following the expansion of the laboratory by 50%, the company...(read more)
Eye-opening new study about the effect of too much time in front of TVs/iPads/laptops, etc.: Screen-Based Entertainment Time, All-Cause Mortality, and Cardiovascular Events Objectives : The aim of this...(read more)
(Benzinga, 11/4/10)
Goldman Sachs has published a research report on Covance, Inc. (NYSE: CVD) after the company reported 3Q EPS directly in-line with Goldman Sachs and Consensus. In the report, Goldman Sachs writes "CVD reported adjusted 3Q EPS of $0.50...(read more)
Covance (CVD) Company Overview

There is no analysis for CVD yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here